A window into the intoxicated mind? Speech as an index of psychoactive drug effects

Neuropsychopharmacology

Volumn 39, Issue 10, 2014, Pages 2340-2348

  Bedi, Gillinder ^a,b   Cecchi, Guillermo A ^c   Slezak, Diego F ^d   Carrillo, Facundo ^d   Sigman, Mariano ^d   De Wit, Harriet ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c IBM T J WATSON RESEARCH CENTER   (United States)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; METHAMPHETAMINE; PLACEBO; PSYCHOTROPIC AGENT; STREET DRUG;

ADULT; ARTICLE; CONCEPT ANALYSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EMPATHY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTOXICATION; MACHINE LEARNING; MALE; MENTAL HEALTH; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEMANTICS; SPEECH ANALYSIS; ADOLESCENT; ARTIFICIAL INTELLIGENCE; AUTOMATED PATTERN RECOGNITION; DRUG DEPENDENCE; DRUG EFFECTS; MENTAL FUNCTION; PSYCHOLOGY; SPEECH; YOUNG ADULT;

ADOLESCENT; ADULT; ARTIFICIAL INTELLIGENCE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MENTAL PROCESSES; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PATTERN RECOGNITION, AUTOMATED; PSYCHOTROPIC DRUGS; SEMANTICS; SPEECH; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84906320793     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.80     Document Type: Article

References (49)

1. Adler CM, Goldberg T, Malhotra AK, Pickar D, Breier A (1998). Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol Psychiatry 43: 811-816
2. Adler CM, Malhotra AK, Elman I, Goldberg T, Egan M, Pickar D et al (1999). Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am J Psychiatry 156: 1646-1649
3. Bedi G, Hyman D, de Wit H (2010). Is ecstasy an 'empathogen': Effects of MDMA on prosocial feelings and identification of emotional states in others. Biol Psychiatry 68: 1134-1140
4. Bedi G, Phan KL, Angstadt M, de Wit H (2009). Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology 207: 73-83
5. Bird S, Klein E, Loper E (2009). Natural Language Processing with Python. O'Reilly Media: Sebastopol, CA
6. Cami J, Farre M, Mas M, Roset PN, Poudevida S, Mas A et al (2000). Human pharmacology of 3, 4-methylenedioxymethamphetamine ("Ecstasy"): Psychomotor performance and subjective effects. J Clin Psychopharmacol 20: 455-466
7. Carter LP, Griffiths RR (2009). Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug Alcohol Depend 105: S14-S25
8. Cohen AS, Yunjung K, Najolia GM (2013). Psychiatric symptom versus neurocognitive correlates of diminished expressivity in schizophrenia and mood disorders. Schiz Res 146: 249-253
9. Cohen AS, Najolia GM, Yunjung K, Dinzeo TJ (2012). On the boundaries of blunt affect/alogia across severe mental illness: Implications for Research Domain Criteria. Schiz Res 140: 41-45
10. Covington MA, Riedel WJ, Bron C, He C, Morris E, Weinsten S et al (2007). Does ketamine mimic aspects of schizophrenic speech? J Psychopharmacol 21: 338-346
11. Coyle J, Presti D, Baggott M (2012). Quantitative analysis of narrative reports of psychedelic drugs. arXiv 1206.0312 [q-bioQM]
12. Deerwester SC, Dumais ST, Landauer TK, Furnas GW, Harshman RA (1990). Indexing by latent semantic analysis. JASIS 41: 391-407
13. Diuk C, Fernandez Slezak D, Raskovsky I, Sigman M, Cecchi GA (2012). A quantitative philology of introspection. Front Integr Neurosci 6: 80
14. Dumont GJ, Sweep FC, Van Der Steen R, Hermsen R, Donders AR, Touw DJ et al (2009). Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3, 4-methylenedioxymethamphetamine) administration. Soc Neurosci 4: 359-366
15. Dumont GJH, Verkes RJ (2006). A review of acute effects of 3, 4-methylenedioxymethamphetmine in healthy volunteers. J Psychopharmacol 20: 176-187
16. Elvevåg B, Foltz PW, Weinberger DR, Goldberg TE (2007). Quantifying incoherence in speech: An automated methodology and novel application to schizophrenia. Schiz Res 93: 304-316
17. Fellbaum C (2010). WordNet. In Poli R Healy M Kameas A (eds) Theory and Applications of Ontology: Computer Applications. Springer: Berlin, Germany
18. Ferrer I, Cancho R, Solé RV (2001). The small world of human language. Proc R Soc Lond B Biol Sci 268: 2261-2265
19. Fischman MW, Foltin RW (2006). Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addict 86: 1563-1570
20. Foltin R, Fischman M (1988). Effects of smoked marijuana on human social behavior in small groups. Pharmacol Biochem Behav 30: 539-541
21. Haney M, Ward A, Comer S, Foltin R, Fischman M (1999). Abstinence symptoms following oral THC administration to humans. Psychopharmacology 141: 385-394
22. Higgins ST, Stitzer ML (1986). Acute marijuana effects on social conversation. Psychopharmacology 89: 234-238
23. Higgins ST, Stitzer ML (1988). Effects of alcohol on speaking in isolated humans. Psychopharmacology 95: 189-194
24. Hughes B, Winstock AR (2012). Controlling new drugs under marketing regulations. Addiction 107: 1894-1899
25. Huxley A (1970). The Doors of Perception. Perennial Library
26. Hysek CM, Schmid Y, Simmler LD, Domes G, Heinrichs M, Eisenegger C et al (2013). MDMA enhances emotional empathy and prosocial behavior. Soc Cogn Affect Neurosci (in press
27. Hysek CM, Simmler LD, Ineichen M, Grouzmann E, Hoener MC, Brenneisen R et al (2011). The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans. Clin Pharmacol Ther 90: 246-255
28. Landauer TK, Dumais ST (1998). A solution to Plato's problem: The latent semantic analysis theory of acquisition, induction, and representation of knowledge. Psychol Rev 104: 211
29. Liechti ME, Vollenweider FX (2001). Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. Hum Psychopharmacol 16: 590-598
30. Low LS, Maddage NC, Lech M, Sheeber LB, Allen NB (2011). Detection of clinical depression in adolescents' speech during family interactions. IEEE Trans Biomed Eng 58: 574-586
31. Lund K, Burgess C (1996). Producing high-dimensional semantic spaces from lexical co-occurrence. Behav Res Methods Instrum Comput 28: 203-208
32. Marrone GF, Pardo J, Krauss R, Hart C (2010). Amphetamine analogs methamphetamine and 3, 4-methylenedioxymethamphetamine (MDMA) differentially affect speech. Psychopharmacology 208: 169-177
33. Miller GA, Charles WG (1991). Contextual correlates of semantic similarity. Lang Cogn Proc 6: 1-28
34. Mitchell SH, Laurent CL, de Wit H (1996). Interaction of expectancy and the pharmacological effects of d-Amphetamine: Subjective effects and self-Administration. Psychopharmacology 125: 371-378
35. Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R (2011). The safety and efficacy of {/-}3, 4-methylenedioxymethamphetamine-Assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study. J Psychopharmacol 25: 439-452
36. Mota NB, Furtado R, Maia PPC, Capelli M, Ribeiro S (2014). Graph analysis of dream reports is especially informative about psychosis. Sci Rep 4: 3691
37. Mota NB, Vasconcelos NA, Lemos N, Pieretti AC, Kinouchi O, Cecchi GA et al (2012). Speech graphs provide a quantitative measure of thought disorder in psychosis. PLoS One 7: E34928
38. Ooi KE, Lech M, Allen NB (2013). Multichannel weighted speech classification system for prediction of major depression in adolescents. IEEE Trans Biomed Eng 60: 497-506
39. Patwardhan S, Banerjee S, Pedersen T (2003). Using measures of semantic relatedness for word sense disambiguation. Proceedings of the Fourth International Conference on Intelligent Text Processing and Computational Linguistics 2003. Springer: Mexico City, Mexico
40. Pedersen T, Patwardhan S, Michelizzi J (2004). WordNet: Similarity: Measuring the relatedness of concepts. Proceedings of the Nineteenth National Conference on Artificial Intelligence 2004. Association for Computational Linguistics: San Jose, CA
41. Quine WVO (1951). Two dogmas of empiricism. Philos Rev 60: 20-43
42. Ramos L, Hicks C, Kevin R, Caminer A, Narlawar R, Kassiou M et al (2013). Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3, 4-methylenedioxymethamphetamine in rats: Involvement of the V1A receptor. Neuropsychopharmacology 38: 2249-2259
43. Rice P, Ezzy D (1999). Qualitative Research Methods, A Health Focus. Oxford University Press: Melbourne, Australia
44. Sigman M, Cecchi GA (2002). Global organization of the Wordnet lexicon. Proc Natl Acad Sci USA 99: 1742-1747
45. Stitzer ML, McCaul ME, Bigelow GE, Liebson IA (1984). Hydromorphone effects on human conversational speech. Psychopharmacology 84: 402-404
46. Sumnall HR, Cole JC, Jerome L (2006). The varieties of ecstasy experience: An exploration of the subjective experiences of ecstasy. J Psychopharmacol 20: 670-682
47. Tagamets MA, Cortes CR, Greigo JA, Elvevåg B (2013). Neural correlates of the relationship between discourse coherence and sensory monitoring in schizophrenia. Cortex (in press
48. Thompson MR, Callaghan PD, Hunt GE, Cornish JL, McGregor IS (2007). A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3, 4-methylenedioxymethamphetamine ("ecstasy"). Neuroscience 146: 509-514
49. Wardle MC, Garner MJ, Munafo MR, de Wit H (2012). Amphetamine as a social drug: Effects of d-Amphetamine on social processing and behavior. Psychopharmacology 223: 199-210